During the past decade, ICON Early Phase Services, LLC conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 4 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "ICON Early Phase Services, LLC" #1 sponsor was "Bristol-Myers Squibb" with 6 trials, followed by "Bayer" with 2 trials sponsored, "Gannex Pharma Co., Ltd." with 2 trials sponsored, "Ology Bioservices" with 2 trials sponsored and "Pfizer" with 2 trials sponsored. Other sponsors include 15 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "ICON Early Phase Services, LLC" #1 collaborator was "National Institutes of Health (NIH)" with 2 trials as a collaborator, "Enabling Biotechnologies (EB)" with 1 trials as a collaborator, "ICON Clinical Research" with 1 trials as a collaborator, "ICON Early Phase Services, LLC" with 1 trials as a collaborator and "National Institute of Allergy and Infectious Diseases (NIAID)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "ICON Early Phase Services, LLC" are "Healthy" (8 trials), "Healthy Volunteers" (3 trials), "Hepatitis C" (3 trials), "Diabetes Mellitus, Type 2" (2 trials) and "Healthy Subjects" (2 trials). Many other conditions were trialed in "ICON Early Phase Services, LLC" in a lesser frequency.

Most popular intervention types in "ICON Early Phase Services, LLC" are "Drug" (30 trials), "Biological" (3 trials), "Device" (3 trials), "Other" (2 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (14 trials), "BMS-986020" (2 trials), "Midazolam" (2 trials), "Naproxen sodium and diphenhydramine hydrochloride soft capsules" (2 trials) and "ADM03820" (1 trials). Other intervention names were less common.

The vast majority of trials in "ICON Early Phase Services, LLC" are 32 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "ICON Early Phase Services, LLC". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 28 completed trials in ICON Early Phase Services, LLC, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in ICON Early Phase Services, LLC, 28 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".